2nd year Cancer Biology PhD candidate in the Majeti Lab at Stanford (Fall ‘22) 🦀 | NSF GRFP | Formerly with the Pietras Lab at CU Anschutz | CU Boulder ‘17
Dr. Minhajuddin at @CUMedicalSchool and team show that venetoclax/dasatinib is a leukemia stem cell (LSC) selective regimen in blast phase CML and that disrupting LIPA and fatty acid transport enhances venetoclax/dasatinib response in targeting LSCs.
bit.ly/3xzrHK5
“If I cannot be a child, then let me be a scientist… because scientists have boundless curiosity and an unrestrained imagination.”
med.stanford.edu/news/all-ne…
ISEH is proud to announce the winners of our 2024 Society Awards!
Scientific Award Winners: Emmanuelle Passegué, Ravindra 'Ravi' Majeti and Robert Signer
Leadership Award Winners: Ross Levine and Katherine King
Read more about this year's winners here 👉 simplyblood.org
Delighted to share our new work in @BloodJournal led by the outstanding and creative Dr. Kira Young! Kira embarked on a journey to understand why individual organisms exhibit natural variation in hematopoietic aging phenotypes. Interesting question! doi.org/10.1182/blood.202402…
Delighted and honored to share that I was awarded the NSF GRFP. Extremely thankful for my current @majetilab and former mentors @pietras_eric@JLeeLab as well as my graduate program @stanfordcbio.
Congratulations to all other recipients and to all of the honorable mentions!
Excited to share our work on ASXL1 mutations in clonal hematopoiesis and myeloid malignancies, out in Blood Cancer Discovery @BCD_AACRdoi.org/10.1158/2643-3230.BC…
Congratulations to the labs newest PhD candidates James Chavez (@James_S_Chavez), Cassandra Stawicki (@C_M_Stawicki) and Emma Heaton (@EmmaSHeaton), who all passed their qualifying exams over the past weeks!
Excited to share our review article in @BloodJournal on the Causes and Consequences of Clonal Hematopoeisis
This was fun to write. Hope it summarizes the state of the field to date.
As always, shout out to the 🐐, Ben Ebert!
ashpublications.org/blood/ar…
Our latest work, led by @PhilRauchMD and @Jk_Gopakumar in collaboration with Ben Ebert, Peter Libby, and others, on mouse models of atherosclerosis with loss of Tet2 or Dnmt3a! Really fortunate to be able to work with such a talented group. rdcu.be/dlcy1
Happy to share our work identifying common pathways promoting heightened innate immune cell activation with loss of either Dnmt3a or Tet2, the two most commonly mutated genes in CHIP, in the context of atherosclerosis.
nature.com/articles/s44161-0…
Researchers at @UFHealthCancer@UFHealth have discovered how common age-related changes in the blood system can make certain colon cancers grow faster.
Read the press release: bit.ly/3ORtoqR
Original article: bit.ly/3KVoJTz
Happy to share our work in @jclinicalinvest on RUNX1 loss in leukemic progression. Using primary human samples, we find a targetable dependency of RUNX1-mutant leukemias on IL-3/JAK/STAT signaling. Magnificent work by @amycfanphd!
Check it out ➡️ jci.org/articles/view/167053